Farallon Capital Management »

Aeon Biopharma I shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Aeon Biopharma I (AEON.WS) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Aeon Biopharma I

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma I held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma I by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.5k 50k 0.15

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Activision Blizzard
Horizon Therapeutics Pub L SHS
UnitedHealth (UNH)
Transunion (TRU)
Exelixis (EXEL)
Iqvia Holdings (IQV)
Thermo Fisher Scientific (TMO)
salesforce (CRM)
Charter Communications Inc N Cl A (CHTR)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Aramark Hldgs (ARMK)
Astrazeneca Sponsored Adr (AZN)
S&p Global (SPGI)

View all positions for Farallon Capital Management

Top funds holding Aeon Biopharma I

Cantor Fitzgerald, L. P.
Davidson Kempner Capital Management
Aristeia Capital
LMR Partners
Tenor Capital Management
D. E. Shaw & Co
Millennium Management
Hudson Bay Capital Management
Whitebox Advisors
Wolverine Asset Management
Kim
Calamos Advisors
Goldman Sachs Group
Sandia Investment Management
Walleye Trading Advisors

View all funds holding Aeon Biopharma I